Ding, Li published the artcileSmoking-cessation drugs and the related technological progress, Quality Control of 375815-87-5, the publication is Shanghai Yiyao (2007), 28(4), 170-172, database is CAplus.
A review. At present, smoking has been a serious social problem. Smoking-cessation drugs and the related technol. are developing in a variety of directions. The development of nicotine replacement therapy and technol., chem. drugs (amfebutamone hydrochloride, varenicline tartrate and rimonabant), vaccine, tradition Chinese medicines, and acupuncture therapy are reviewed with 3 references
Shanghai Yiyao published new progress about 375815-87-5. 375815-87-5 belongs to quinoxaline, auxiliary class Neuronal Signaling,AChR,Natural product, name is 7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate, and the molecular formula is C17H19N3O6, Quality Control of 375815-87-5.
Referemce:
https://en.wikipedia.org/wiki/Quinoxaline,
Quinoxaline | C8H6N2 | ChemSpider